Purchase Order 75N91020P00581

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on March 22, 2018, for $24,531.78, with completion by May 31, 2018. The order procures laboratory supplies and consumables. Place of performance is Carlsbad, California.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,960 on July 19, 2017, for laboratory supplies, with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation, reagents, and consumables supplied across federal research and diagnostic sectors.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $14,599.10 on July 18, 2017, for laboratory supplies with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs across the life sciences...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $24,898.13 on August 30, 2018, with ultimate completion on August 29, 2019. No set-aside category applied. Place of performance is Bethesda, Maryland. The purchase order uses fixed-price pricing with economic price adjustment. Life Technologies operates as Thermo Fisher Scientific and supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation for biological kits valued at $13,697.04, awarded July 9, 2019, with ultimate completion August 8, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price commercial item pricing with no set-aside applied.</p>

The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...

<p>The National Cancer Institute issued a delivery order to Life Technologies Corporation on January 13, 2020, with a ceiling value of $42,072.38 for BigDye Terminator V1.1 cycle sequencing kit and reagents and consumables for Applied Biosystems 3500XL and 3730XL genetic analyzers.</p> <p>Place of performance is Carlsbad, CA. The order is firm fixed price and completes April 30, 2020. Life Technologies is a subsidiary of Thermo Fisher Scientific Inc.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>